These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34529172)

  • 1. Clinical Relevance of Gastroesophageal Cancer Associated SNPs for Oncologic Outcome After Curative Surgery.
    Jung JO; Wirsik NM; Nienhüser H; Peters L; Müller-Stich BP; Hess T; Schüller V; Schumacher J; Schmidt T
    Ann Surg Oncol; 2022 Feb; 29(2):1453-1462. PubMed ID: 34529172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MAGEA10 expression is a predictive marker of early hepatic recurrence after curative gastrectomy for gastric and gastroesophageal junction cancer.
    Fujiya K; Terashima M; Ohshima K; Aizawa D; Sugino T; Serizawa M; Nakamura K; Nagashima T; Hatakeyama K; Urakami K; Akiyama Y; Tsubosa Y; Kitagawa Y; Yamaguchi K
    Gastric Cancer; 2021 Mar; 24(2):341-351. PubMed ID: 32965606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An A/C germline single-nucleotide polymorphism in the TNFAIP3 gene is associated with advanced disease stage and survival in only surgically treated esophageal cancer.
    Ghadban T; Schmidt-Yang M; Uzunoglu FG; Perez DR; Tsui TY; El Gammal AT; Erbes PJ; Zilbermints V; Wellner U; Pantel K; Izbicki JR; Vashist YK
    J Hum Genet; 2014 Dec; 59(12):661-6. PubMed ID: 25354935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms in MGMT and DNA repair genes and the risk of esophageal adenocarcinoma.
    Doecke J; Zhao ZZ; Pandeya N; Sadeghi S; Stark M; Green AC; Hayward NK; Webb PM; Whiteman DC;
    Int J Cancer; 2008 Jul; 123(1):174-80. PubMed ID: 18386788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA repair gene and MTHFR gene polymorphisms as prognostic markers in locally advanced adenocarcinoma of the esophagus or stomach treated with cisplatin and 5-fluorouracil-based neoadjuvant chemotherapy.
    Ott K; Rachakonda PS; Panzram B; Keller G; Lordick F; Becker K; Langer R; Buechler M; Hemminki K; Kumar R
    Ann Surg Oncol; 2011 Sep; 18(9):2688-98. PubMed ID: 21347786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association analysis of ERBB2 amplicon genetic polymorphisms and STARD3 expression with risk of gastric cancer in the Chinese population.
    Qiu Y; Zhang ZY; Du WD; Ye L; Xu S; Zuo XB; Zhou FS; Chen G; Ma XL; Schneider ME; Xia HZ; Zhou Y; Wu JF; Yuan-Hong X; Zhang XJ
    Gene; 2014 Feb; 535(2):225-32. PubMed ID: 24291029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single nucleotide polymorphism rs13042395 in the SLC52A3 gene as a biomarker for regional lymph node metastasis and relapse-free survival of esophageal squamous cell carcinoma patients.
    Tan HZ; Wu ZY; Wu JY; Long L; Jiao JW; Peng YH; Xu YW; Li SS; Wang W; Zhang JJ; Li EM; Xu LY
    BMC Cancer; 2016 Jul; 16():560. PubMed ID: 27472962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlation of aberrant methylation of MGMT gene to MTHFR C677T genetic polymorphisms in esophageal squamous cell carcinoma].
    Xue HC; Wang JM; Xu B; Guo GP; Hua ZL; Zhou Q; Zhu ZH; Ma ZK; Gao J
    Ai Zheng; 2008 Dec; 27(12):1256-62. PubMed ID: 19079989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tumoral A genotype of the MGMT rs34180180 single-nucleotide polymorphism in aggressive gliomas is associated with shorter patients' survival.
    Fogli A; Chautard E; Vaurs-Barrière C; Pereira B; Müller-Barthélémy M; Court F; Biau J; Pinto AA; Kémény JL; Khalil T; Karayan-Tapon L; Verrelle P; Costa BM; Arnaud P
    Carcinogenesis; 2016 Feb; 37(2):169-176. PubMed ID: 26717998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance and outcomes after curative resection for gastroesophageal adenocarcinoma.
    Jiang DM; Suzuki C; Espin-Garcia O; Lim CH; Ma LX; Sun P; Sim HW; Natori A; Chan BA; Moignard S; Chen EX; Liu G; Swallow CJ; Darling GE; Wong R; Jang RW; Elimova E
    Cancer Med; 2020 May; 9(9):3023-3032. PubMed ID: 32130793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FAM46C Serves as a Predictor of Hepatic Recurrence in Patients with Resectable Gastric Cancer.
    Tanaka H; Kanda M; Shimizu D; Tanaka C; Kobayashi D; Hayashi M; Iwata N; Yamada S; Fujii T; Nakayama G; Sugimoto H; Fujiwara M; Niwa Y; Kodera Y
    Ann Surg Oncol; 2017 Oct; 24(11):3438-3445. PubMed ID: 27770343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profile prospectively predicts peritoneal relapse after curative surgery of gastric cancer.
    Takeno A; Takemasa I; Seno S; Yamasaki M; Motoori M; Miyata H; Nakajima K; Takiguchi S; Fujiwara Y; Nishida T; Okayama T; Matsubara K; Takenaka Y; Matsuda H; Monden M; Mori M; Doki Y
    Ann Surg Oncol; 2010 Apr; 17(4):1033-42. PubMed ID: 20012501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of miRNA-related genetic polymorphisms and prognosis in patients with esophageal squamous cell carcinoma.
    Yang PW; Huang YC; Hsieh CY; Hua KT; Huang YT; Chiang TH; Chen JS; Huang PM; Hsu HH; Kuo SW; Kuo ML; Lee JM
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S601-9. PubMed ID: 24770678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anastomotic leak predicts diminished long-term survival after resection for gastric and esophageal cancer.
    Andreou A; Biebl M; Dadras M; Struecker B; Sauer IM; Thuss-Patience PC; Chopra S; Fikatas P; Bahra M; Seehofer D; Pratschke J; Schmidt SC
    Surgery; 2016 Jul; 160(1):191-203. PubMed ID: 27067160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with early recurrence after curative surgery for gastric cancer.
    Kang WM; Meng QB; Yu JC; Ma ZQ; Li ZT
    World J Gastroenterol; 2015 May; 21(19):5934-40. PubMed ID: 26019458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic impact of O6-Methylguanine-DNA Methyltransferase (MGMT) promotor hypermethylation in esophageal adenocarcinoma.
    Baumann S; Keller G; Pühringer F; Napieralski R; Feith M; Langer R; Höfler H; Stein HJ; Sarbia M
    Int J Cancer; 2006 Jul; 119(2):264-8. PubMed ID: 16477636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copine 5 expression predicts prognosis following curative resection of esophageal squamous cell carcinoma.
    Umeda S; Kanda M; Koike M; Tanaka H; Miwa T; Tanaka C; Kobayashi D; Suenaga M; Hayashi M; Yamada S; Nakayama G; Kodera Y
    Oncol Rep; 2018 Dec; 40(6):3772-3780. PubMed ID: 30272363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of overall and recurrence-free survival after neoadjuvant chemotherapy for gastroesophageal adenocarcinoma: Pooled analysis of individual patient data (IPD) from randomized controlled trials (RCTs).
    Ronellenfitsch U; Schwarzbach M; Hofheinz R; Kienle P; Nowak K; Kieser M; Slanger TE; Burmeister B; Kelsen D; Niedzwiecki D; Schuhmacher C; Urba S; van de Velde C; Walsh TN; Ychou M; Jensen K
    Eur J Surg Oncol; 2017 Aug; 43(8):1550-1558. PubMed ID: 28551325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An individual coding polymorphism and the haplotype of the SPARC gene predict gastric cancer recurrence.
    Winder T; Wilson PM; Yang D; Zhang W; Ning Y; Power DG; Bohanes P; Gerger A; Tang LH; Shah M; Lenz HJ
    Pharmacogenomics J; 2013 Aug; 13(4):342-8. PubMed ID: 22491017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphisms of vascular endothelial growth factor (VEGF) associated with gastric cancer recurrence after curative resection with adjuvant chemotherapy.
    Kim YJ; Chung WC; Jun KH; Chin HM
    BMC Cancer; 2019 May; 19(1):483. PubMed ID: 31117964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.